Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy ProgramGlobeNewsWire • 12/02/22
Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual MeetingGlobeNewsWire • 11/07/22
Nkarta Reports Second Quarter 2022 Financial Results and Corporate HighlightsGlobeNewsWire • 08/11/22
Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should KnowZacks Investment Research • 06/07/22
Can Nkarta, Inc. (NKTX) Climb 383% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 05/18/22
Nkarta Announces Closing of Upsized Public Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional SharesGlobeNewsWire • 04/28/22